Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?

Mitchell Kamrava; John V. Hegde; Narine Abgaryan; Edward Chang; Jesse D. Le; Jason Wang; Patrick A. Kupelian; Leonard S. Marks

doi:10.1111/bju.13082

Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?

Mitchell Kamrava, John V. Hegde, Narine Abgaryan, Edward Chang, Jesse D. Le, Jason Wang, Patrick A. Kupelian, Leonard S. Marks

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	584-591
Number of pages	8
Journal	BJU International
Volume	117
Issue number	4
DOIs	https://doi.org/10.1111/bju.13082
State	Published - Apr 1 2016
Externally published	Yes

ASJC Scopus Subject Areas

Urology

Keywords

MRI-guided biopsy
prostate cancer
radiotherapy
risk stratification

Access to Document

10.1111/bju.13082

OpenUrl availability

Full text

Cite this

@article{43de5747475744d2b633216a38ef5687,

title = "Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?",

keywords = "MRI-guided biopsy, prostate cancer, radiotherapy, risk stratification",

author = "Mitchell Kamrava and Hegde, {John V.} and Narine Abgaryan and Edward Chang and Le, {Jesse D.} and Jason Wang and Kupelian, {Patrick A.} and Marks, {Leonard S.}",

note = "Publisher Copyright: {\textcopyright} 2015 The Authors BJU International. {\textcopyright} 2015 BJU International Published by John Wiley & Sons Ltd.",

year = "2016",

month = apr,

day = "1",

doi = "10.1111/bju.13082",

language = "English",

volume = "117",

pages = "584--591",

journal = "BJU International",